Who published this market news?

Reuters published this market news item.

Reuters

Vertex to buy Crinetics in $10 billion deal

7/7/2026, 04:08 am GMT+8 Reuters

Sources: Reuters
Markets: Stocks
Active symbols: NASDAQ:CRNX, NASDAQ:VRTX
Language: English (India)

Vertex Pharmaceuticals NASDAQ:VRTX will buy Crinetics Pharmaceuticals NASDAQ:CRNX for a total equity value of about $10 billion, the companies said on Monday.